CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability
| Image |  |
|---|---|
| Description | scientific article published on 19 October 2010 |
| Author/s |
author: Jeffrey W. Tyner Marc M Loriaux John C. Byrd Brian Druker |
| Publication date | October 19, 2010 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |